Population Pharmacokinetics and Pharmacodynamics of Gabapentin After Administration of Gabapentin Enacarbil

Clinical Pharmacokinetics of Gabapentin After Administration of Gabapentin Enacarbil Extended-Release Tablets in Patients With Varying Degrees of Renal Function Using Data From an Open-Label, Single-Dose Pharmacokinetic Study

(2011) Ritu Lal et al.   CLINICAL THERAPEUTICS

Dopamine Agonist Withdrawal Syndrome in Parkinson Disease

(2010) Christina A. Rabinak et al.   ARCHIVES OF NEUROLOGY

Clinical pharmacokinetic drug interaction studies of gabapentin enacarbil, a novel transported prodrug of gabapentin, with naproxen and cimetidine

(2010) Ritu Lal et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Long-term Maintenance Treatment of Restless Legs Syndrome With Gabapentin Enacarbil: A Randomized Controlled Study

(2010) Richard K. Bogan et al.   MAYO CLINIC PROCEEDINGS

Restless legs syndrome: Understanding its consequences and the need for better treatment

(2010) Christopher J. Earley et al.   SLEEP MEDICINE

Gabapentin Enacarbil in Restless Legs Syndrome

(2009) Arthur S. Walters et al.   CLINICAL NEUROPHARMACOLOGY

Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: A randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers

(2009) Ritu Lal et al.   CLINICAL THERAPEUTICS

Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS

(2009) C. A. Kushida et al.   NEUROLOGY

A Population Pharmacokinetic Model of Gabapentin Developed in Nonparametric Adaptive Grid and Nonlinear Mixed Effects Modeling

(2009) Kristin C Carlsson et al.   THERAPEUTIC DRUG MONITORING

Clinical Pharmacokinetics of XP13512, a Novel Transported Prodrug of Gabapentin

(2008) Kenneth C. Cundy et al.   JOURNAL OF CLINICAL PHARMACOLOGY